LSE - Delayed Quote GBp
Bioventix PLC (BVXP.L)
2,500.00
0.00
(0.00%)
At close: 4:25:59 PM GMT+1
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Operating Cash Flow
8,344.14
8,344.14
7,802.36
7,557.11
6,337.31
Investing Cash Flow
186.06
186.06
90.51
-6.95
-229.20
Financing Cash Flow
-8,247.06
-8,247.06
-8,303.70
-7,918.49
-7,689.59
End Cash Position
5,998.95
5,998.95
5,715.82
6,126.65
6,494.99
Capital Expenditure
-15.91
-15.91
-10.58
-11.76
-260.33
Issuance of Capital Stock
--
--
139.36
--
20.22
Free Cash Flow
8,328.23
8,328.23
7,791.77
7,545.35
6,076.98
6/30/2021 - 4/29/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
GXE.BE Galapagos NV
23.04
+2.77%
4880.T CellSource Co., Ltd.
644.00
-1.38%
HVO.L hVIVO plc
16.35
-0.15%
FARN.L Faron Pharmaceuticals Oy
202.50
-3.57%
IBT.L International Biotechnology Trust plc
586.00
+1.03%
AVCT.L Avacta Group Plc
31.00
-6.06%
ONT.L Oxford Nanopore Technologies plc
122.10
+1.33%
GLPG.AS Galapagos NV
22.98
+2.32%
RIGL Rigel Pharmaceuticals, Inc.
19.06
+4.96%
GMAB.CO Genmab A/S
1,340.00
+0.75%